RJA
CFRX

Raymond James & Associates’s ContraFect Corporation CFRX Stock Holding History

Raymond James & Associates’s Portfolio CFRX Stock Details CFRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-144
Closed -$47K – 4387
2021
Q3 		$47K Hold
144
– – ﹤0.01% 3922
2021
Q2 		$51K Hold
144
– – ﹤0.01% 3916
2021
Q1 		$55K Buy
+144
New +$62.1K ﹤0.01% 3847

Other funds holding CFRX

Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
OIM
Oracle Investment Management Greenwich, Connecticut $168M AUM 42.86% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return
FI
Fosun International Hong Kong, China $399M AUM 16.11% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
MCM
Moore Capital Management New York $4.92B AUM 35.41% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Raymond James & Associates's CFRX Position: Q4 2021 in Review

Raymond James & Associates sold out of ContraFect Corporation (CFRX) in Q4 2021, closing a stake of 144 shares — an estimated $47K sold.

Raymond James & Associates first reported a position in CFRX in Q1 2021 and held it in 3 quarters. The position peaked at $55K in Q1 2021. 59 funds tracked by Wall St. Rank hold CFRX as of Q4 2021.

  • Raymond James & Associates reported no remaining ContraFect Corporation position as of Q4 2021 after selling out during the quarter.
  • Raymond James & Associates sold 144 ContraFect Corporation shares in Q4 2021, an estimated $47K.
  • Raymond James & Associates first reported a position in ContraFect Corporation in Q1 2021 and held it in 3 quarters.
  • Raymond James & Associates's ContraFect Corporation position peaked at $55K in Q1 2021.
  • 59 funds tracked by Wall St. Rank held ContraFect Corporation as of Q4 2021.

Based on Raymond James & Associates's 13F filing for Q4 2021, filed 8 Feb 2022.